| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2019 | TEVA PHARMACEUTICALS USA, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$410,000 | |
| 2019 | TEVA PHARMACEUTICALS USA, INC. |
2nd Quarter (Apr 1 - June 30) AMENDED |
$780,000 | |
| 2019 | TEVA PHARMACEUTICALS USA, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$480,000 | |
| 2019 | TEVA PHARMACEUTICALS USA, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$340,000 | |
| 2019 | TEVA PHARMACEUTICALS USA, INC. |
1st Quarter (Jan 1 - Mar 31) AMENDED |
$740,000 | |
| 2019 | TEVA PHARMACEUTICALS USA, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$720,000 |
| Firm | Filings | Expenses |
|---|---|---|
| TEVA PHARMACEUTICALS USA, INC. | 87 | $61,910,000 |
| Issue | Activities |
|---|---|
| Health Issues | 65 |
| Trade (domestic/foreign) | 51 |
| Pharmacy | 43 |
| Copyright/Patent/Trademark | 39 |
| Tariff (miscellaneous tariff bills) | 11 |
| Budget/Appropriations | 7 |
| Medicare/Medicaid | 7 |
| Taxation/Internal Revenue Code | 4 |